Sign In
Buy AI
$9.86
-0.0500 (-0.505%)
At Close: Aug 06, 2026
Is Most-Watched Stock C3.ai, Inc. (AI) Worth Betting on Now?
10:01am, Monday, 22'nd Dec 2025
C3.ai (AI) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
C3.ai: Unresolved Issues
10:00am, Sunday, 21'st Dec 2025
C3.ai is rebounding after a challenging period, with revenues bouncing off yearly lows and a new CEO at the helm. AI's subscription and license revenues showed sequential improvement, but remain well
Better AI Stock: SoundHound AI vs. C3.ai
02:19pm, Saturday, 20'th Dec 2025
SoundHound AI and C3.ai were both developing AI-powered products long before the generative AI boom started in late 2022. C3.ai trades at 5.5 times sales, while SoundHound AI commands a much steeper 3
Thomas Siebel Sells 140,768 Shares of C3.ai (NYSE:AI) Stock
05:02am, Saturday, 20'th Dec 2025
C3.ai, Inc. (NYSE: AI - Get Free Report) Chairman Thomas Siebel sold 140,768 shares of C3.ai stock in a transaction that occurred on Wednesday, December 17th. The stock was sold at an average price of
The Genesis Mission Has a 270-Day Timeline – And You’re Already Late
12:00am, Saturday, 20'th Dec 2025
The government is taking equity stakes in American companies. Here are the next Genesis Mission stocks to buy before the capital hits.
Miss These Genesis Mission Stocks, and You’ll Regret It for a Decade
12:00am, Saturday, 20'th Dec 2025
The government is taking equity stakes in American companies. Here are the next Genesis Mission stocks to buy before the capital hits.
Can C3.ai's IPD-Led Sales Reset Support a More Durable Growth Path?
10:35am, Thursday, 18'th Dec 2025
AI shifts sales to IPD-led deployments, favoring smaller proofs of value to drive disciplined conversions and build a more durable growth path.
Should You Buy C3.ai Stock After Its 55% Drop in 2025? Here's What Wall Street Thinks.
04:07am, Monday, 15'th Dec 2025
C3.ai offers over 130 turnkey software applications designed to help businesses speed up their adoption of artificial intelligence (AI). C3.ai's founder and longtime CEO stepped away in September to d
Stock Traders Buy Large Volume of C3.ai Call Options (NYSE:AI)
01:14am, Saturday, 13'th Dec 2025
C3.ai, Inc. (NYSE: AI - Get Free Report) saw some unusual options trading activity on Friday. Stock investors purchased 170,377 call options on the stock. This is an increase of approximately 75% comp
Why I'm Expecting A Year-End Rally, And Another Big Year Next Year!
03:50pm, Friday, 12'th Dec 2025
It's been another outstanding year for stocks in 2025, but the outlook for 2026 could be even more lucrative. Kevin Matras will help you take full advantage of this raging bull market by finding the b
Federated Hermes Inc. Sells 65,263 Shares of C3.ai, Inc. $AI
03:51am, Friday, 12'th Dec 2025
Federated Hermes Inc. trimmed its holdings in C3.ai, Inc. (NYSE: AI) by 16.7% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. Th
Is C3.ai Stock a Buy Now?
12:58pm, Thursday, 11'th Dec 2025
Shares of C3.ai have pulled back substantially, but there are signs of a potential turnaround. C3.ai's guidance for the current year suggests a significant decline in the top line.
C3.ai Stock Slides 35% in 6 Months, Buy the Dip or Stay Cautious?
09:56am, Thursday, 11'th Dec 2025
AI's 35% slide spotlights sales missteps, margin pressure and shutdown impacts even as bookings rebound and partnerships expand.
C3 AI Achieves FedRAMP Authorization
09:00am, Thursday, 11'th Dec 2025
REDWOOD CITY, Calif.--(BUSINESS WIRE)--C3 AI (NYSE: AI) the Enterprise AI software company, today announced it achieved FedRAMP (Federal Risk and Authorization Management Program) authorization. FedRA
High-Quality Compounders With Both Pricing Power And Idiosyncratic Growth
03:45am, Thursday, 11'th Dec 2025
The Touchstone Mid Cap Growth Fund outperformed its benchmark, the Russell Midcap® Growth Index, for the quarter ended September 30, 2025. From a factor perspective, the Fund's overweight exposure to
